Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
authFullName_s : Jacques Moreau

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years

Gilles Boschetti , Stephane Nancey , Fady Daniel , Benjamin Pariente , Eric Lerebours , et al.
Inflammatory Bowel Diseases, 2016, 22 (12), pp.2924-2932. ⟨10.1097/MIB.0000000000000967⟩
Article dans une revue hal-03553388v1

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

Parambir S. Dulai , Aurélien Amiot , Laurent Peyrin-Biroulet , Vipul Jairaith , Mélanie Serrero , et al.
Alimentary Pharmacology and Therapeutics, 2020, 51 (5), pp.553-564. ⟨10.1111/apt.15609⟩
Article dans une revue hal-03552288v1

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort study (CREOLE)

Yoram Bouhnik , Franck Carbonnel , David Laharie , Carmen Stefanescu , Xavier Hebuterne , et al.
10. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2015, Barcelone, Spain. ⟨10.1093/ecco-jcc/jju027.062⟩
Communication dans un congrès hal-03553418v1
Image document

Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine

David Laharie , Arnaud Bourreille , Julien Branche , Matthieu Allez , Yoram Bouhnik , et al.
Clinical Gastroenterology and Hepatology, 2021, 19 (6), pp.1180-1188.e4. ⟨10.1016/j.cgh.2020.08.001⟩
Article dans une revue hal-03551241v1

The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study

Aurélien Amiot , Jean-Charles Grimaud , Xavier Treton , Jérôme Filippi , Benjamin Pariente , et al.
11. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2016, Amsterdam, Netherlands
Communication dans un congrès hal-03553395v1